Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.

Aydogan T, Sezgin E, Ilvan S, Yilmaz OC, Aslan N, Golshan M, Aydogan F.

Clin Breast Cancer. 2019 Sep 16. pii: S1526-8209(19)30672-X. doi: 10.1016/j.clbc.2019.09.002. [Epub ahead of print]

PMID:
31699672
2.

Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.

Golshan M, Wong SM, Loibl S, Huober JB, O'Shaughnessy J, Rugo HS, Wolmark N, Ansell P, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE Jr, Sikov WM, Untch M.

Eur J Surg Oncol. 2019 Oct 5. pii: S0748-7983(19)30883-2. doi: 10.1016/j.ejso.2019.10.002. [Epub ahead of print]

PMID:
31606288
3.

Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach.

Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA.

Ann Surg Oncol. 2019 Sep 27. doi: 10.1245/s10434-019-07785-y. [Epub ahead of print]

PMID:
31562601
4.

Bilateral mastectomy operations and the role for the cosurgeon technique: A Nationwide analysis of surgical practice patterns.

Mallory MA, Valero MG, Hu J, Barry WT, Losk K, Nimbkar S, Golshan M.

Breast J. 2019 Sep 9. doi: 10.1111/tbj.13522. [Epub ahead of print]

PMID:
31498509
5.

Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.

Warren LEG, Chen YH, Halasz LM, Brock JE, Capuco A, Punglia RS, Wong JS, Golshan M, Bellon JR.

Breast Cancer Res Treat. 2019 Dec;178(3):607-615. doi: 10.1007/s10549-019-05428-0. Epub 2019 Sep 6.

PMID:
31493031
6.

ASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward.

Özkurt E, Golshan M.

Ann Surg Oncol. 2019 Aug 29. doi: 10.1245/s10434-019-07759-0. [Epub ahead of print] No abstract available.

PMID:
31468219
7.

Androgen signaling in male fishes: Examples of anti-androgenic chemicals that cause reproductive disorders.

Golshan M, Alavi SMH.

Theriogenology. 2019 Nov;139:58-71. doi: 10.1016/j.theriogenology.2019.07.020. Epub 2019 Jul 19.

PMID:
31369937
8.

Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.

Wong SM, Weiss A, Mittendorf EA, King TA, Golshan M.

Ann Surg Oncol. 2019 Oct;26(11):3517-3525. doi: 10.1245/s10434-019-07583-6. Epub 2019 Jul 24.

PMID:
31342389
9.

National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015.

Wong SM, Chun YS, Sagara Y, Golshan M, Erdmann-Sager J.

Ann Surg Oncol. 2019 Oct;26(10):3194-3203. doi: 10.1245/s10434-019-07554-x. Epub 2019 Jul 24.

PMID:
31342383
10.

Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?

Özkurt E, Sakai T, Wong SM, Tukenmez M, Golshan M.

Ann Surg Oncol. 2019 Oct;26(10):3260-3268. doi: 10.1245/s10434-019-07534-1. Epub 2019 Jul 24.

PMID:
31342356
11.

Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising.

Zinboonyahgoon N, Vlassakov K, Lirk P, Spivey T, King T, Dominici L, Golshan M, Strichartz G, Edwards R, Schreiber K.

Br J Anaesth. 2019 Aug;123(2):e293-e302. doi: 10.1016/j.bja.2019.01.041. Epub 2019 Mar 28.

PMID:
31331591
12.

National trends of synchronous bilateral breast cancer incidence in the United States.

Sakai T, Ozkurt E, DeSantis S, Wong SM, Rosenbaum L, Zheng H, Golshan M.

Breast Cancer Res Treat. 2019 Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.

PMID:
31325072
13.

Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.

Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA.

Ann Surg Oncol. 2019 Oct;26(11):3502-3509. doi: 10.1245/s10434-019-07517-2. Epub 2019 Jun 21.

PMID:
31228134
14.

Metabolic stress leads to divergent changes in the ghrelinergic system in goldfish (Carassius auratus) gonads.

Rajeswari JJ, Hatef A, Golshan M, Alavi SMH, Unniappan S.

Comp Biochem Physiol A Mol Integr Physiol. 2019 Sep;235:112-120. doi: 10.1016/j.cbpa.2019.05.027. Epub 2019 May 31.

PMID:
31158494
15.

Graphene Decorated with Silver Nanoparticles as a Low-Temperature Methane Gas Sensor.

Ghanbari R, Safaiee R, Sheikhi MH, Golshan MM, Horastani ZK.

ACS Appl Mater Interfaces. 2019 Jun 19;11(24):21795-21806. doi: 10.1021/acsami.9b00625. Epub 2019 Jun 4.

PMID:
31120237
16.

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study.

Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, Pun M, Campbell N, Dowling RJO, Chang MC, Tolaney S, Chagpar AB, Yung RL, Freedman RA, Dominici LS, Golshan M, Rhei E, Taneja K, Huang Y, Brown M, Winer EP, Jeselsohn R, Irwin ML.

Clin Cancer Res. 2019 Sep 1;25(17):5398-5406. doi: 10.1158/1078-0432.CCR-18-3143. Epub 2019 Apr 24.

PMID:
31018921
17.

Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program.

Cole AP, Krasnova A, Ramaswamy A, Fletcher SA, Friedlander DF, McNabb-Baltar J, Melnitchouk N, Lipsitz SR, Sun M, Kibel AS, Golshan M, Haider AH, Weissman JS, Trinh QD.

J Oncol Pract. 2019 Jun;15(6):e547-e559. doi: 10.1200/JOP.18.00352. Epub 2019 Apr 18.

PMID:
30998420
18.

Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.

Cole AP, Nguyen DD, Meirkhanov A, Golshan M, Melnitchouk N, Lipsitz SR, Kilbridge KL, Kibel AS, Cooper Z, Weissman J, Trinh QD.

JAMA Netw Open. 2019 Feb 1;2(2):e187633. doi: 10.1001/jamanetworkopen.2018.7633.

19.

Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study.

Heshmati K, Harris DA, Rosner B, Pranckevicius E, Ardestani A, Cho N, Golshan M, Ng WT, Ligibel J, Tavakkoli A, Sheu E.

Obes Surg. 2019 Apr;29(4):1092-1098. doi: 10.1007/s11695-018-03701-7.

PMID:
30659466
20.

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS).

Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA.

JNCI Cancer Spectr. 2018 Nov;2(4):pky063. doi: 10.1093/jncics/pky063. Epub 2018 Dec 27.

21.

Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer.

Whorms DS, Giess CS, Golshan M, Freedman RA, Bunnell CA, Alper EC, Losk K, Khorasani R.

J Am Coll Radiol. 2019 Jun;16(6):814-823. doi: 10.1016/j.jacr.2018.10.010. Epub 2018 Dec 20.

PMID:
30579707
22.

Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery.

Schreiber KL, Zinboonyahgoon N, Xu X, Spivey T, King T, Dominici L, Partridge A, Golshan M, Strichartz G, Edwards RR.

J Pain. 2019 May;20(5):540-556. doi: 10.1016/j.jpain.2018.11.004. Epub 2018 Nov 23.

PMID:
30476655
23.

An ensemble prediction of flood susceptibility using multivariate discriminant analysis, classification and regression trees, and support vector machines.

Choubin B, Moradi E, Golshan M, Adamowski J, Sajedi-Hosseini F, Mosavi A.

Sci Total Environ. 2019 Feb 15;651(Pt 2):2087-2096. doi: 10.1016/j.scitotenv.2018.10.064. Epub 2018 Oct 6.

PMID:
30321730
24.

Going the Distance: Ethical Issues Arising When Patients Seek Cancer Care From International Settings.

Benedetti DJ, Golshan M, Kesselheim JC.

J Glob Oncol. 2018 Sep;4:1-4. doi: 10.1200/JGO.17.00001. Epub 2017 Jun 9. No abstract available.

25.

Data on photo-catalytic degradation of 4- chlorophenol from aqueous solution using UV/ZnO/persulfate.

Ahmadi M, Samarbaf S, Golshan M, Jorfi S, Ramavandi B.

Data Brief. 2018 Aug 29;20:582-586. doi: 10.1016/j.dib.2018.08.076. eCollection 2018 Oct.

26.

Correction to: Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.

Choi J, Laws A, Hu J, Barry W, Golshan M, King T.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):995. doi: 10.1245/s10434-018-6721-1.

PMID:
30145646
27.

Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy.

Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA.

Ann Surg Oncol. 2018 Nov;25(12):3548-3555. doi: 10.1245/s10434-018-6696-y. Epub 2018 Aug 20.

PMID:
30128903
28.

Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.

Choi J, Laws A, Hu J, Barry W, Golshan M, King T.

Ann Surg Oncol. 2018 Nov;25(12):3541-3547. doi: 10.1245/s10434-018-6702-4. Epub 2018 Aug 20. Erratum in: Ann Surg Oncol. 2018 Aug 25;:.

PMID:
30128902
29.

Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.

Natsuhara KH, Losk K, King TA, Lin NU, Camuso K, Golshan M, Pochebit S, Brock JE, Bunnell CA, Freedman RA.

Oncologist. 2019 May;24(5):595-602. doi: 10.1634/theoncologist.2018-0154. Epub 2018 Aug 3.

PMID:
30076279
30.

Photocatalytic activation of peroxymonosulfate by TiO2 anchored on cupper ferrite (TiO2@CuFe2O4) into 2,4-D degradation: Process feasibility, mechanism and pathway.

Golshan M, Kakavandi B, Ahmadi M, Azizi M.

J Hazard Mater. 2018 Oct 5;359:325-337. doi: 10.1016/j.jhazmat.2018.06.069. Epub 2018 Jul 8.

PMID:
30048947
31.

De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease?

Barbie TU, Golshan M.

Ann Surg Oncol. 2018 Oct;25(11):3109-3111. doi: 10.1245/s10434-018-6664-6. Epub 2018 Jul 17. No abstract available.

PMID:
30019303
32.

Chronic Pain After Breast Surgery: A Prospective, Observational Study.

Spivey TL, Gutowski ED, Zinboonyahgoon N, King TA, Dominici L, Edwards RR, Golshan M, Schreiber KL.

Ann Surg Oncol. 2018 Oct;25(10):2917-2924. doi: 10.1245/s10434-018-6644-x. Epub 2018 Jul 16.

PMID:
30014456
33.

Management of In-Breast Tumor Recurrence.

Wong SM, Golshan M.

Ann Surg Oncol. 2018 Oct;25(10):2846-2851. doi: 10.1245/s10434-018-6605-4. Epub 2018 Jun 26. Review.

PMID:
29947005
34.

Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.

Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA.

Ann Surg Oncol. 2018 Nov;25(12):3527-3534. doi: 10.1245/s10434-018-6525-3. Epub 2018 Jun 4.

PMID:
29868979
35.

Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery.

Valero MG, Mallory MA, Losk K, Tukenmez M, Hwang J, Camuso K, Bunnell C, King T, Golshan M.

Ann Surg Oncol. 2018 Sep;25(9):2573-2578. doi: 10.1245/s10434-018-6526-2. Epub 2018 May 21.

36.

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.

Criscitiello C, Golshan M, Barry WT, Viale G, Wong S, Santangelo M, Curigliano G.

Eur J Cancer. 2018 Jul;97:1-6. doi: 10.1016/j.ejca.2018.03.023. Epub 2018 May 17.

PMID:
29734046
37.

Bilateral mastectomies: can a co-surgeon technique offer improvements over the single-surgeon method?

Mallory MA, Tarabanis C, Schneider E, Nimbkar S, Golshan M.

Breast Cancer Res Treat. 2018 Aug;170(3):641-646. doi: 10.1007/s10549-018-4794-y. Epub 2018 Apr 23.

38.

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.

Loibl S, O'Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, Huober J, Golshan M, von Minckwitz G, Maag D, Sullivan D, Wolmark N, McIntyre K, Ponce Lorenzo JJ, Metzger Filho O, Rastogi P, Symmans WF, Liu X, Geyer CE Jr.

Lancet Oncol. 2018 Apr;19(4):497-509. doi: 10.1016/S1470-2045(18)30111-6. Epub 2018 Feb 28.

PMID:
29501363
39.

Management of the Axilla in Early Breast Cancer.

Valero MG, Golshan M.

Cancer Treat Res. 2018;173:39-52. doi: 10.1007/978-3-319-70197-4_4. Review.

PMID:
29349757
40.

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.

Sagara Y, Julia W, Golshan M, Toi M.

Front Oncol. 2017 Aug 28;7:192. doi: 10.3389/fonc.2017.00192. eCollection 2017. Review.

41.

Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation.

Losk K, Freedman RA, Lin NU, Golshan M, Pochebit SM, Lester SC, Natsuhara K, Camuso K, King TA, Bunnell CA.

J Oncol Pract. 2017 Sep;13(9):e815-e820. doi: 10.1200/JOP.2017.023788. Epub 2017 Aug 31. Erratum in: J Oncol Pract. 2017 Nov;13(11):776.

PMID:
28858535
42.

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.

Sagara Y, Freedman RA, Wong SM, Aydogan F, Nguyen A, Barry WT, Golshan M.

Breast Cancer Res Treat. 2017 Nov;166(2):583-592. doi: 10.1007/s10549-017-4436-9. Epub 2017 Aug 3.

PMID:
28776282
43.

Complex sclerosing lesions and radial sclerosing lesions on core needle biopsy: Low risk of carcinoma on excision in cases with clinical and imaging concordance.

Nakhlis F, Lester S, Denison C, Wong SM, Mongiu A, Golshan M.

Breast J. 2018 Mar;24(2):133-138. doi: 10.1111/tbj.12859. Epub 2017 Jul 7.

PMID:
28685897
44.

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.

Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, Dominici LS, Golshan M, Jacene HA, Yeh ED, Mullaney EE, Overmoyer B.

Ann Surg Oncol. 2017 Sep;24(9):2563-2569. doi: 10.1245/s10434-017-5903-6. Epub 2017 May 30.

PMID:
28560598
45.

Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.

Wong SM, King T, Boileau JF, Barry WT, Golshan M.

Ann Surg Oncol. 2017 Sep;24(9):2509-2517. doi: 10.1245/s10434-017-5867-6. Epub 2017 Apr 28.

PMID:
28455673
46.

Synthesis and characterization of poly(propylene imine)-dendrimer-grafted gold nanoparticles as nanocarriers of doxorubicin.

Golshan M, Salami-Kalajahi M, Mirshekarpour M, Roghani-Mamaqani H, Mohammadi M.

Colloids Surf B Biointerfaces. 2017 Jul 1;155:257-265. doi: 10.1016/j.colsurfb.2017.04.029. Epub 2017 Apr 13.

PMID:
28433942
47.

Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery.

Mallory MA, Sagara Y, Aydogan F, DeSantis S, Jayender J, Caragacianu D, Gombos E, Vosburgh KG, Jolesz FA, Golshan M.

Breast J. 2017 Nov;23(6):713-717. doi: 10.1111/tbj.12796. Epub 2017 Mar 10.

48.

Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.

Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M.

Cancer. 2017 Jul 15;123(14):2609-2617. doi: 10.1002/cncr.30644. Epub 2017 Feb 21.

49.

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M.

Ann Surg. 2017 Mar;265(3):581-589. doi: 10.1097/SLA.0000000000001698.

PMID:
28169929
50.

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).

Ollila DW, Cirrincione CT, Berry DA, Carey LA, Sikov WM, Hudis CA, Winer EP, Golshan M.

J Am Coll Surg. 2017 Apr;224(4):688-694. doi: 10.1016/j.jamcollsurg.2016.12.036. Epub 2017 Jan 13.

Supplemental Content

Loading ...
Support Center